Patients who received osteopenia treatment had a longer OS than those who did not, although the difference did not reach statistical significance ( P =0.097) ( Supplementary Figure 8B ).
← all excerpts
Bone mineral density as an individual prognostic biomarker in NSCLC patients treated with immune checkpoint inhibitors.
1
0.0970
0.0970